BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 4269624)

  • 21. The thymus origin of the carrier-specific cell in an anti-hapten response in vitro.
    Trowbridge IS; Anderson HR
    Eur J Immunol; 1972 Dec; 2(6):565-70. PubMed ID: 4540163
    [No Abstract]   [Full Text] [Related]  

  • 22. Long-term survival of mouse thymic lymphoid cells in vitro: effect of human serum.
    Ozato K
    J Immunol; 1973 Nov; 111(5):1459-69. PubMed ID: 4270393
    [No Abstract]   [Full Text] [Related]  

  • 23. Mitogenic factors produced by lymphocyte activation: effect on T- and B-cells.
    Vischer TL
    J Immunol; 1972 Aug; 109(2):401-2. PubMed ID: 4558542
    [No Abstract]   [Full Text] [Related]  

  • 24. Functional heterogeneity of murine lymphoid cells. I. Responsiveness to and surface binding of concanavalin A and phytohemagglutinin.
    Stobo JD; Rosenthal AS; Paul WE
    J Immunol; 1972 Jan; 108(1):1-17. PubMed ID: 5010393
    [No Abstract]   [Full Text] [Related]  

  • 25. Search for suppression of T cells specific for the second nonhost H-2 haplotype in F1 leads to P irradiation bone marrow chimeras.
    Zinkernagel RM; Althage A
    J Immunol; 1979 May; 122(5):1742-9. PubMed ID: 156219
    [No Abstract]   [Full Text] [Related]  

  • 26. Differentiation of functionally active mouse T-lymphocytes from functionally inactive bone marrow precursors.
    Gorczynski RM; MacRae S
    Immunology; 1977 Nov; 33(5):697-712. PubMed ID: 145406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological expressions of lymphocyte activation. IV. Concanavalin A-activated suppressor cells in mouse mixed lymphocyte reactions.
    Rich RR; Rich SS
    J Immunol; 1975 Mar; 114(3):1112-5. PubMed ID: 122989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Graft versus leukemia. 3. Apparent independent anthost and antileukemia activity of transplanted immunocompetent cells.
    Bortin MM; Rimm AA; Saltzstein EC; Rodey GE
    Transplantation; 1973 Sep; 16(3):182-8. PubMed ID: 4147030
    [No Abstract]   [Full Text] [Related]  

  • 29. Mouse bone marrow lymphocytes and their differentiation.
    Ryser JE; Vassalli P
    J Immunol; 1974 Sep; 113(3):719-28. PubMed ID: 4213258
    [No Abstract]   [Full Text] [Related]  

  • 30. Involvement of T lymphocytes in the pathogenesis of coxsackie virus B3 heart disease.
    Woodruff JF; Woodruff JJ
    J Immunol; 1974 Dec; 113(6):1726-34. PubMed ID: 4610045
    [No Abstract]   [Full Text] [Related]  

  • 31. The role of humoral factors in the initiation of in vitro primary immune responses. II. Effects of lymphocyte mitogens.
    Watson J; Epstein R; Nakoinz I; Ralph P
    J Immunol; 1973 Jan; 110(1):43-52. PubMed ID: 4568187
    [No Abstract]   [Full Text] [Related]  

  • 32. The splenic suppressor cell. II. Suppression of mixed lymphocyte reaction by thymus-dependent adherent cells.
    Folch H; Waksman BH
    J Immunol; 1974 Jul; 113(1):140-4. PubMed ID: 4275548
    [No Abstract]   [Full Text] [Related]  

  • 33. Relationship between proliferative and effector phases of the mixed lymphocyte reaction and graft-vs-host reaction.
    Howe M; Berman L; Cohen L
    J Immunol; 1973 Oct; 111(4):1243-9. PubMed ID: 4147022
    [No Abstract]   [Full Text] [Related]  

  • 34. Cell-mediated immune responses in vitro. V. A comparative study of in vitro immunogenicity of splenic lymphocytes, neoplastic lymphoid cells and fibroblats.
    Wagner H; Wyss C
    Eur J Immunol; 1973 Sep; 3(9):549-55. PubMed ID: 4271926
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibition of normal allogeneic responder cells in mouse mixed leukocyte culture by long-passage AKR leukemic lymphoblasts.
    Rodey GE; Sprader JC; Bortin MM
    Cancer Res; 1974 Jun; 34(6):1289-94. PubMed ID: 4275007
    [No Abstract]   [Full Text] [Related]  

  • 36. [Mitogenic activity of a bacterial phospholipid extract on murine lymphocytes (author's transl)].
    Marchal G; Fauve RM
    Ann Immunol (Paris); 1974; 125(3):507-18. PubMed ID: 4605791
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro reconstitution of T cell deficient mouse spleen cells by co-cultivation with human lymphocytes.
    Farrar JJ
    J Immunol; 1974 Apr; 112(4):1613-6. PubMed ID: 4273629
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of rough endoplasmic reticulum in mouse splenic lymphocytes stimulated by mitogens.
    Shohat M; Janossy G; Dourmashkin RR
    Eur J Immunol; 1973 Nov; 3(11):680-7. PubMed ID: 4589168
    [No Abstract]   [Full Text] [Related]  

  • 39. Properties of fractionated spleen cells from NZB/W mice.
    Garner GM; Gershwin ME; Steinberg AD
    Cell Immunol; 1975 Jan; 15(1):129-42. PubMed ID: 45836
    [No Abstract]   [Full Text] [Related]  

  • 40. Specific unresponsiveness to skin allografts in anti-lymphocyte serum-treated, marrow-injected mice: participation of donor marrow-derived suppressor T cells.
    Maki T; Gottschalk R; Wood ML; Monaco AP
    J Immunol; 1981 Oct; 127(4):1433-8. PubMed ID: 6168692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.